In this study, we have evaluated the contributions of the JAK/STAT and MAPK/ERK1,2 signalling pathways on mROS generation in HSVSMCs from T2DM and non-diabetic patients. This evidence concerns the gene MAPK3 and type 2 diabetes mellitus.